A Single Dose Study of LY2605541 in Participants With Liver Impairment

Clinical trial NCT01751399 · COMPLETED

Trial details

NCT number: NCT01751399
Sponsor: Eli Lilly and Company
Status: COMPLETED
Phase: Phase 1
Study type: INTERVENTIONAL

Healthy Volunteers Hepatic Insufficiency Diabetes Mellitus, Type 2

Start date: 2012-12-01
Primary completion: 2013-09-01
Enrollment: 35

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.